Snow mold allergies are creating unexpected healthcare challenges in New Jersey as melting winter snow releases fungal spores, driving increased demand for allergy treatments and medications. The phenomenon affects productivity across multiple industries as workers suffer from respiratory symptoms.

Two mold species, Microdochium nivale (pink) and Typhula incarnata (grey), thrive in the 35-55°F temperature range common during spring thaws. This seasonal trigger creates a predictable surge in healthcare utilization, with pharmacies reporting upticks in antihistamine and inhaler purchases.

Pharmaceutical companies and healthcare providers benefit from this annual pattern, though the economic impact extends beyond direct medical costs. Workers with untreated allergies experience reduced productivity, affecting businesses in New Jersey and similar regions with heavy snowfall. Healthcare systems must prepare resources to address this predictable seasonal demand.